ghk-cu human clinical trial hair growth GHK Peptide (2016) — Research Summary ghk-cu hair growth topical study
Description
(2014) 147:101220 e4
BPC-157 is administered as a subcutaneous injection (a shallow, small-needle injection into fatty tissue, similar to an insulin injection)
Pereda, E., Quiroga, R
However, GH responses to diabetes are different in rats and humans
Traditional growth hormone therapy carries risks including fluid retention, joint pain (paradoxically), carpal tunnel syndrome, and increased cancer risk
